METFORMIN IN THE PREVENTION OF METABOLIC SYNDROME ASSOCIATED WITH INITIATION OF ATYPICAL ANTIPSYCHOTIC THERAPY IN ADOLESCENTS AND YOUNG ADULTS - A RANDOMIZED, OPEN LABELLED, SINGLE CENTERED STUDY
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2016, Vol 8, Issue 4
Abstract
Objective: The aim of the study was to evaluate the effectiveness and safety of Metformin along with Risperidone to prevent antipsychotic-induced metabolic syndrome in first-episode schizophrenia patients.Methods: This was a randomized, open labelled, prospective study conducted in the Department of psychiatry, Tirunelveli medical college. Around 96 patients diagnosed with first episode schizophrenia were randomized into 2 groups. Group 1 patients were given T. Risperidone (2 mg twice daily, n=48) and group 2 patients were given T. Metformin (500 mg twice daily, n=48) along with T. Risperidone for 6 mo.The primary endpoint assessed was the proportion of patients developing metabolic syndrome at the end of 6 mo in both the groups. The secondary endpoints were the changes in body mass index (BMI), waist circumference (WC), fasting blood sugar (FBS) and triglycerides (TGL) from baseline to the end point.Results: There was a significant reduction in BMI and WC at the end of 3 mo (p<0.001) and at the end of 6 mo (p<0.001) when compared to baseline in group II individuals. There was a significant reduction in FBS and TGL levels at the end of 6 mo of treatment (p<0.001) in group II individuals. There was the significant statistical difference between both the groups (p<0.05) in terms of BMI, WC, FBS, triglycerides. The treatment emergent adverse effects with Metformin were generally mild and did not lead to any discontinuation.Conclusion: The use of Metformin along with Risperidone may have a better impact on the long-term cardiovascular morbidity and mortality of the schizophrenia patients. Keywords: Schizophrenia, Metabolic syndrome, Atypical antipsychotics, Body mass index, Waist circumference, Fasting blood sugar, Triglycerides
Authors and Affiliations
R. Vishnupriya, J. Ezhilramya, B. Meenakshi
Keywords
Related Articles
- EP ID EP577734
- DOI -
- Views 38
- Downloads 1
FORMULATION AND EVALUATION OF MATRIX TABLET OF VENLAFAXINE HCL BY USING DIRECTLY COMPRESSIBLE CO-PROCESSED EXCIPIENT
Objective: The sustained release of drug from the dosage form is useful especially for achieving controlled plasma level of the drug as well as improving bioavailability. The objective of the present work was to release...
ANTIBACTERIAL ACTIVITY OF AEGLE MARMELOS (L) CORREA
Objective: To investigate the antibacterial property of Aegle marmelos (L.) Correa leaf extracts.Methods: The antibacterial property of A. marmelos crude methanolic and chloroform leaf extracts was evaluated through ag...
MICROBICIDAL POTENTIALITY OF PURIFIED ANTHOCYANIN FROM IN VITRO CULTURE OF CLERODENDRON INFORTUNATUM L. AGAINST SELECTED PATHOGENS
Objective: Clerodendron infortunatum L. is a widely used medicinal herb over centuries for curing many skin-borne disorders. The present study was designed to validate the tribal knowledge by evaluating antimicrobial pot...
FORMULATION, OPTIMIZATION AND IN VITRO EVALUATION OF GASTRORETENTIVE MUCOADHESIVE MICROSPHERES OF FUROSEMIDE
Objective: The objective of this study was to formulate and evaluate sustained release gastro retentive microspheres of furosemide using mucoadhesive polymers. It was expected that gastro retention plus mucoadhesion woul...
FORMULATION AND EVALUATION OF NEVIRAPINE MUCOADHESIVE MICROSPHERES
Objective: The objective of the present research was to formulate and evaluate HPMC K4M, HPMC K100, and Carbopol 940 Mucoadhesive microspheres in combination with sodium alginate for controlling release of Nevirapine. Me...